Trial intelligence / Profile preview

Intrathecal Prilocaine Doses in Elderly Surgery

NCT05726968Phase 3Completed

Sponsor
Cairo University
Start
Nov 2022
Primary completion
Jun 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of prilocaine in inguinal hernia, femoral hernia, incisional hernia and 4 more (3 arms), sponsored by Cairo University. Primary endpoint: Duration of motor Block in hours at 1 day. Started Nov 2022; status: completed.

02

Drugs

prilocaine
03

Conditions

inguinal herniafemoral herniaincisional herniavaricocelehydrocele

Beyond the preview

Go deeper on NCT05726968.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05726968.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call